BRIDGE invites you to their event

Prof Seufferlein, Where do we stand in mPaCa?

About this event

In this webinar, Prof Seufferlein will discuss the management of mPaCa. He will provide an overview of positive phase 3 trials, treatments approved in mPaCa, and guideline recommendations vs. treatment management in the clinical practice.


The presentation will be followed by a Live Q&A session during which you will be able to directly send your questions to Prof Seufferlein.

Hosted by

  • Guest speaker
    G
    Prof. Dr. Thomas Seufferlein Medical Director @ Clinic for Internal Medicine I, University Hospital Ulm, Germany

    Prof Seufferlein serves as Medical Director of the Clinic for Internal Medicine I at the University Hospital of Ulm and is chairman of the Committee for Cancer Prevention of the German Cancer Aid. His scientific work focuses on gastrointestinal tumors, especially pancreatic cancer.

BRIDGE

BRIDGE is an initiative by Servier that connects health care professionals worldwide to share knowledge on gastrointestinal (GI) cancers and their management.